Baillie Gifford & Co’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
ACH
FLAM
PA
Baillie Gifford & Co's AXGN Position: Q3 2022 in Review
Baillie Gifford & Co sold out of Axogen (AXGN) in Q3 2022, closing a stake of 444 shares — an estimated $4K sold.
Baillie Gifford & Co first reported a position in AXGN in Q3 2018 and held it in 16 quarters. The position peaked at $25.2M in Q2 2021. 126 funds tracked by Wall St. Rank hold AXGN as of Q3 2022.
- Baillie Gifford & Co reported no remaining Axogen position as of Q3 2022 after selling out during the quarter.
- Baillie Gifford & Co sold 444 Axogen shares in Q3 2022, an estimated $4K.
- Baillie Gifford & Co first reported a position in Axogen in Q3 2018 and held it in 16 quarters.
- Baillie Gifford & Co's Axogen position peaked at $25.2M in Q2 2021.
- 126 funds tracked by Wall St. Rank held Axogen as of Q3 2022.
Based on Baillie Gifford & Co's 13F filing for Q3 2022, filed 27 Oct 2022.